Literature DB >> 10387109

Kinetic properties of purified Pseudomonas aeruginosa phosphorylcholine phosphatase indicated that this enzyme may be utilized by the bacteria to colonize in different environments.

M A Salvano1, C E Domenech.   

Abstract

Pseudomonas aeruginosa phosphorylcholine phosphatase from periplasmic extracts of bacteria grown on choline as the sole carbon and nitrogen source was purified to homogeneity. The enzyme represented nearly 1% of the total protein found in the periplasmic space and is a monomer of approximately 53 kDa with an isoelectric point of 7.5. The optimum pH with phosphorylcholine was in the range of 5-8; with phosphorylethanolamine there was a peak at pH 6, and with p-nitrophenyl-phosphate (p-NPP) the optimum was at pH 5. Studies carried out at pH 5 indicated: i) For the three substrates above, Mg2+, Zn2+, or Cu2+ was necessary for maximal activity. ii) With p-NPP, these cations bound to the free enzyme in an ordered bireactant system. iii) With phosphorylethanolamine, Mg2+, Zn2+, or Cu2+ bound to the free enzyme in an at random bireactant system. iv) With phosphorylcholine, maximal activity was obtained with cation concentrations as low as 100 nM. v) Al3+ ions were inhibitors of the enzyme activity. The n (Hill coefficient) values for the inhibition by Al3+ with phosphorylcholine or p-NPP were 1 or 4, respectively. vi) The enzyme exhibited two affinity sites for phosphorylcholine. With Mg2+, a site with a Km value of 0.5 mM was detected; the corresponding Vmax was 25 micromol min-1 (mg protein)-1; without Mg2+, the enzyme displayed Km and Vmax values of 0.09 mM and 4.2 micromol min-1 (mg protein)-1, respectively. Studies carried out at pH 7.4 indicated: i) The enzyme could not catalyze the hydrolysis of p-NPP, and phosphorylethanolamine was a poor substrate in either the presence or absence of divalent cations. ii) The enzyme activity measured with phosphorylcholine was independent of divalent cations or was not inhibited by Al3+ ions. iii) With or without Mg2+, the enzyme exhibited two affinity sites for phosphorylcholine; the Km values were 0.05 mM and 0.5 mM with their corresponding Vmax of 5.6 and 25 micromol min-1 (mg protein)-1, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10387109     DOI: 10.1007/pl00006819

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  6 in total

1.  Legionella pneumophila major acid phosphatase and its role in intracellular infection.

Authors:  V Aragon; S Kurtz; N P Cianciotto
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Identification, cloning, and expression of Pseudomonas aeruginosa phosphorylcholine phosphatase gene.

Authors:  María J Massimelli; Paola R Beassoni; Marina A Forrellad; José L Barra; Mónica N Garrido; Carlos E Domenech; Angela T Lisa
Journal:  Curr Microbiol       Date:  2005-05       Impact factor: 2.188

3.  Critical active-site residues identified by site-directed mutagenesis in Pseudomonas aeruginosa phosphorylcholine phosphatase, a new member of the haloacid dehalogenases hydrolase superfamily.

Authors:  Paola R Beassoni; Lisandro H Otero; Maria J Massimelli; Angela T Lisa; Carlos E Domenech
Journal:  Curr Microbiol       Date:  2006-11-13       Impact factor: 2.188

4.  Different Effects of Mg and Zn on the Two Sites for Alkylammonium Compounds in Pseudomonas aeruginosa Phosphorylcholine Phosphatase.

Authors:  Lisandro Horacio Otero; Paola Rita Beassoni; Cristhian Boetsch; Angela Teresita Lisa; Carlos Eduardo Domenech
Journal:  Enzyme Res       Date:  2011-05-14

5.  Phosphorylcholine Phosphatase: A Peculiar Enzyme of Pseudomonas aeruginosa.

Authors:  Carlos Eduardo Domenech; Lisandro Horacio Otero; Paola Rita Beassoni; Angela Teresita Lisa
Journal:  Enzyme Res       Date:  2011-09-11

6.  Choline Triggers Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Infected with Pseudomonas aeruginosa.

Authors:  Sandra Grumelli
Journal:  Curr Respir Med Rev       Date:  2016
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.